September 09, 2013
Generic-drug maker Sandoz Inc. on Monday agreed not to make, sell or distribute a version of Merck & Co. Inc.'s anti-cholesterol drug Zetia until 2017, putting to rest Merck's patent infringement suit.
October 02, 2012
Units of Merck & Co. Inc. on Thursday hit generics maker Sandoz Inc. with a patent infringement suit in New Jersey federal court in their latest effort to block generic versions of the anti-cholesterol drug Zetia.